[ESPR] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
23-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -22.28%
YoY- -68.66%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 14,409 40,659 7,978 9,638 3,833 212,236 1,840 293.85%
PBT -69,386 -43,668 -90,935 -104,476 -85,437 124,611 -78,249 -7.69%
Tax 13,667 11,153 8,139 8,795 4,970 4,721 4,539 108.37%
NP -69,386 -43,668 -90,935 -104,476 -85,437 124,611 -78,249 -7.69%
Tax Rate - - - - - -3.79% - -
Total Cost 83,795 84,327 98,913 114,114 89,270 87,625 80,089 3.05%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -481.55 -107.40 -1,139.82 -1,084.00 -2,228.99 58.71 -4,252.66 -76.56%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -2.62 -1.67 -3.50 -3.89 -3.07 4.50 -2.84 -5.22%
EPS Diluted -2.62 -1.67 -3.50 -3.89 -3.07 4.32 -2.84 -5.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.